1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Sickle Cell Disease Regional Care Excellence (SoRCE) Program" is currently closed and not accepting applications.
Sickle Cell Disease Regional Care Excellence (SoRCE) Program is sponsored by HRSA. Enhances the quality of care for individuals with sickle cell disease.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Sickle Cell Disease Regional Care Excellence (SoRCE) Program Sickle Cell Disease Regional Care Excellence (SoRCE) Program Agency: Health Resources and Services Administration Assistance Listings: 93. 365 -- Sickle Cell Treatment Demonstration Program Last Updated: June 5, 2026 View version history on Grants.
gov Sickle Cell Disease Regional Care Excellence Program (SoRCE) is to improve the health of people with sickle cell disease (SCD) by expanding access to care, improving the quality of care, and tracking quality of life indicators. There are approximately 100,000 people in the United States with SCD.
Treatment starting in early childhood can prevent or reduce complications such as severe pain episodes, silent strokes, and premature death. Despite universal identification at birth, fewer than half of children with SCD receive needed treatment. As these children become adolescents and transition to adulthood...
many are not appropriately identified as candidates for disease-modifying therapies, in part because their doctors are still learning how to use the latest treatments. The program is made up of seven regions with one award recipient per region serving as a Regional Coordinating Hub (RCH).
Each award recipient will work with clinical and community-based partners in their region and engage in continuous quality improvement (CQI) initiatives to improve access and quality of care. Public and state institutions of higher education Private institutions of higher education Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Hospitals or clinicsHealth centers.
Grantor contact information File name Description Last updated HRSA-26-052_Final. pdf HRSA-26-052 Final. pdf Jun 23, 2026 05:54 PM UTC HRSA-26-052_TA_Call_Presentation.
pdf HRSA-26-052 TA Call Presentation. pdf Jun 29, 2026 12:09 PM UTC FAQs_HRSA-26-052. pdf FAQs HRSA-26-052.
pdf Jun 30, 2026 10:33 AM UTC Link to additional information Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Hospitals or clinics with at least five years of experience in sickle cell disease care. Confirm the full requirements in the official notice before applying.
The published deadline was July 8, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Sickle Cell Disease Regional Care Excellence (SoRCE) Program is funded by HRSA. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
HRSA-27-006 and HRSA-27-007 post September 18, 2026 and both close October 19 — $711.4 million across 189 awards for service areas that already have a health center in them. The incumbent is defending. Everyone else is holding a free option.
Read articleHRSA-27-099 offers $125 million for 357 awards of $350,000 each to health centers with an active H80 award, closing September 9, 2026. An identical FY2026 round closed June 9 with the same money, the same award count, and a September 1 award date. Here is what back-to-back rounds mean for winners and losers of the first one, and why the 120-day implementation clause is the real commitment.
Read articleOn September 4, 2026, HRSA awarded $11.2 million through the Rural Residency Planning and Development program to build 15 new physician residencies across 14 states. Since 2019 the program has invested nearly $77 million, producing 66 accredited programs and 818 approved positions. Here is what the conversion rate reveals, why the specialty mix is narrowing, and how to build a competitive application for the next cycle.
Read article